3SBio, a China partner of U.S. drug giant Pfizer, has reached agreements to raise approximately $400 million in a share ...

Holmes’ attack on evidence that led to her conviction comes amid an apparent campaign to obtain a pardon from President ...

These five stocks are potential total return champions that could offer investors a smooth ride in 2026, as we could see some ...

Pfizer (PFE) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of ...

Shares of several major vaccine makers lost ground Monday following a report U.S. vaccine approval rules could become ...

More than a year after its promised deadline to investors, drugmaker puts alarming results in federal government's "virtual ...

Most of the dividend increases announced in the last two weeks of November were in the low-to-mid single-digit percentages.

Pfizer Inc. (NYSE:PFE) is one of the best low volatility large cap stocks to invest in. On November 24, Guggenheim lifted the ...

(NYSE:PFE) is one of the stocks Jim Cramer recently shed light on. Cramer highlighted some of the stock’s possible catalysts, ...

Summary • Pfizer’s stock rose 2.6% to $25.04, driven by recent FDA approval of PADCEV® for bladder cancer treatment.• The ...

On Oct. 3, students and employees in Middlesex Community College’s STEM (science, technology, engineering, mathematics) ...

Pfizer sold an aggregate of $6 billion in notes due in the coming years. The pharmaceutical giant sold $500 million of floating rate notes and $1 billion in 3.9% notes, both due in 2027, according to ...